Carisma Therapeutics, Inc. (CARM)
OTCMKTS · Delayed Price · Currency is USD
0.0420
-0.0010 (-2.40%)
At close: Jan 14, 2026
Carisma Therapeutics Market Cap
Carisma Therapeutics has a market cap or net worth of $1.76 million as of January 14, 2026. Its market cap has decreased by -90.47% in one year.
Market Cap
1.76M
Enterprise Value
-256.46K
Revenue
52.63M
Ranking
n/a
PE Ratio
0.22
Stock Price
$0.04
Market Cap Chart
Since March 8, 2023, Carisma Therapeutics's market cap has decreased from 147.73M to 1.76M, a decrease of -98.81%. That is a compound annual growth rate of -78.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 13, 2026 | 1.80M | 0.14% |
| Dec 31, 2025 | 1.80M | -89.71% |
| Dec 31, 2024 | 17.48M | -85.21% |
| Dec 29, 2023 | 118.25M | -19.96% |
| Mar 8, 2023 | 147.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 807.56M |
| Glass House Brands | 728.02M |
| Elite Pharmaceuticals | 497.45M |
| Northwest Biotherapeutics | 421.34M |
| Nika Pharmaceuticals | 395.06M |
| American Oncology Network | 386.20M |
| CytoDyn | 342.70M |
| Silence Therapeutics | 278.68M |